Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	487.55	1,034	943.75	247.19	205.26	139.91
Trading Asset Securities	490	-	-	-	0.74	-
Cash & Short-Term Investments	977.55	1,034	943.75	247.19	206	139.91
Cash Growth	2.82%	9.61%	281.79%	19.99%	47.24%	1.68%
Accounts Receivable	71.47	89.2	57.73	47.3	44.61	39.62
Other Receivables	16.18	15.17	14.94	0.04	2.81	0.35
Receivables	87.65	104.38	72.67	47.34	47.42	39.97
Inventory	118.9	115.48	159.31	142.65	104.94	86.18
Other Current Assets	5.4	3.29	2.25	9.01	2.39	0.89
Total Current Assets	1,189	1,258	1,178	446.19	360.75	266.94
Property, Plant & Equipment	212.44	201.51	134.9	85.64	85.89	64.54
Other Intangible Assets	118.29	20.14	19.78	19.74	20.26	18.15
Long-Term Deferred Tax Assets	-	-	-	1.79	1.37	0.87
Long-Term Deferred Charges	0.1	0.27	0.26	1.8	3.27	5
Other Long-Term Assets	4.41	6.45	8.04	10.45	5.76	7.89
Total Assets	1,525	1,486	1,341	565.6	477.31	363.39
Accounts Payable	46.09	52.16	46.55	34.94	56.28	31.43
Accrued Expenses	13.46	18.21	15.65	14.73	14.97	13.64
Current Portion of Leases	1.23	1.14	0.07	0.78	0.75	-
Current Income Taxes Payable	8.43	9.58	6.05	21.61	11.33	9.73
Current Unearned Revenue	7.83	7.92	4.16	7.08	9.49	5.71
Other Current Liabilities	31.58	33.04	6.3	4.26	10.04	16.61
Total Current Liabilities	108.61	122.04	78.77	83.4	102.86	77.13
Long-Term Leases	7.39	6.98	0.1	-	0.78	-
Long-Term Unearned Revenue	4.84	5.39	5.85	6.22	5.59	3.08
Long-Term Deferred Tax Liabilities	5.52	7.43	6.89	6.7	6.78	4.22
Other Long-Term Liabilities	-	-	-	0.24	-	-
Total Liabilities	126.36	141.84	91.62	96.57	116.02	84.42
Common Stock	151.93	102.65	68	51	51	51
Additional Paid-In Capital	721.74	759.97	763.02	104.3	104.3	104.3
Retained Earnings	548.97	505.63	417.07	312.4	204.88	122.31
Treasury Stock	-25.46	-25.46	-	-	-	-
Comprehensive Income & Other	1.21	1.37	1.25	1.33	1.11	1.35
Shareholders' Equity	1,398	1,344	1,249	469.03	361.29	278.96
Total Liabilities & Equity	1,525	1,486	1,341	565.6	477.31	363.39
Total Debt	8.61	8.12	0.17	0.78	1.53	-
Net Cash (Debt)	968.94	1,026	943.59	246.41	204.47	139.91
Net Cash Growth	2.89%	8.77%	282.94%	20.51%	46.15%	1.68%
Net Cash Per Share	6.40	6.85	6.88	2.21	1.83	1.25
Filing Date Shares Outstanding	149.91	148.95	148.95	111.71	111.71	111.71
Total Common Shares Outstanding	149.91	148.95	148.95	111.71	111.71	111.71
Working Capital	1,081	1,136	1,099	362.78	257.89	189.82
Book Value Per Share	9.33	9.02	8.39	4.20	3.23	2.50
Tangible Book Value	1,280	1,324	1,230	449.29	341.03	260.82
Tangible Book Value Per Share	8.54	8.89	8.25	4.02	3.05	2.33
Buildings	59.66	59.66	55.1	52.99	53.03	38.13
Machinery	158.51	149.06	123.92	107.08	106.47	88.32
Construction In Progress	83.14	73.59	48.05	8.41	0.93	6.19

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.